Global Reach Genepharm has established operations in Greece with a distribution footprint in over 90 countries, presenting a ready-made channel for international generic product expansion and distributor partnerships.

Solid Manufacturing Owned 15,000 m2 facility in Pallini with EU GMP-compliant lines for conventional and oncological solids, offering reliable supply for high-demand categories such as oncology and chronic therapies.

High Capacity Production capacity of up to 500 million tablets and 40 million capsules for conventional forms, plus 140 million tablets and 10 million capsules for oncology, enabling scale-up for volume-driven tenders and private-label programs.

Strategic Ownership Company is privately held and has a history of acquisition by MS Pharma Group, indicating potential for leveraged partnerships, financing options, and accelerated market access strategies.

Therapeutic Focus Broad therapeutic coverage including cardiology, diabetes, oncology, urology, and antipsychotics, suggesting cross-category opportunities for co-promotions, line extensions, and epidemiology-aligned targeting.